CCRNCROSS COUNTRY HEALTHCARE INC(CCRN)Stock Analysis

AI analysis on 2,800+ stocks →
IndustrialsNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 1141103CCRN stock profile & AI dashboard →

13F Pro Quality Score

26.6/100

Rank #2,612 of 2,961 stocks

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

2.7/100

Profitability

18.4/100

Balance Sheet

11.4/100

Earnings Quality

25.7/100

Free Cash Flow

38.6/100

Institutional Flow

31.5/100

Revenue Scale

50.0/100

Dilution Risk

68.0/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

CCRN Stock Analysis & AI Quality Score

Data updated 2026-09-09

AI stock analysis and institutional research for CROSS COUNTRY HEALTHCARE INC (CCRN), a Industrials sector company. 13F Pro's AI-powered ranking engine scores CCRN at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,612 of 2,961 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (2.7) and balance sheet strength (11.4), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), CROSS COUNTRY HEALTHCARE INC reports quarterly revenue of $241.1M, net income of $-4.3M, free cash flow of $3.3M. Top institutional holders of CCRN by reported 13-F value include Boston Partners, BlackRock, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. CCRN trades on the Nasdaq exchange and files with the SEC under CIK 1141103. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CCRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CROSS COUNTRY HEALTHCARE INC directly from SEC EDGAR. CROSS COUNTRY HEALTHCARE INC's 13F Pro composite quality score has ranged between 25 and 70 since 2021, currently 26.6 — a declining long-term trajectory across 67 quarterly and live scoring snapshots.

Revenue

Q1 2026

$241.1M

Net Income

Q1 2026

$-4.3M

Free Cash Flow

Q1 2026

$3.3M

ROIC

Q1 2026

-5.3%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-21.6% YoY
$1.05BFY 2025
FY22 $2.80BFY23 $2.02BFY24 $1.34BFY25 $1.05B

Net Income

-551.6% YoY
$-94.9MFY 2025
FY22 $188.5MFY23 $72.6MFY24 $-14.6MFY25 $-94.9M

Operating Income

-400.5% YoY
$-84.4MFY 2025
FY22 $269.9MFY23 $112.7MFY24 $-16.9MFY25 $-84.4M

EPS (Diluted)

-565.9% YoY
$-2.93FY 2025
FY22 $4.95FY23 $2.05FY24 $-0.44FY25 $-2.93

Total Assets

-23.8% YoY
$449.0MFY 2025
FY22 $949.6MFY23 $681.1MFY24 $589.3MFY25 $449.0M

Total Debt

FY 2025
FY22 $150.7MFY23 FY24 FY25

Op. Cash Flow

-59.8% YoY
$48.3MFY 2025
FY22 $134.1MFY23 $248.5MFY24 $120.1MFY25 $48.3M

Free Cash Flow

-64.0% YoY
$40.1MFY 2025
FY22 $125.3MFY23 $234.5MFY24 $111.4MFY25 $40.1M

Get alerted when CCRN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CROSS COUNTRY HEALTHCARE INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to CCRN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

EEX

Emerald Holding, Inc.

42
AI score
Shared smart-money ownership · 5 shared holders
IMXI

International Money Express, Inc.

37
AI score
Similar quality profile · 13 shared holders
KOP

Koppers Holdings Inc.

39
AI score
Similar quality profile · 5 shared holders
TTEC

TTEC Holdings, Inc.

28
AI score
Similar quality profile · 1 shared holders
WNC

WABASH NATIONAL Corp

26
AI score
Similar quality profile · 3 shared holders
SRI

STONERIDGE INC

25
AI score
Similar quality profile · 3 shared holders
AVNS

AVANOS MEDICAL, INC.

36
AI score
Shared smart-money ownership · 17 shared holders
FOXF

FOX FACTORY HOLDING CORP

30
AI score
Similar quality profile · 4 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put CCRN on your watchlist

Track score changes the day CROSS COUNTRY HEALTHCARE INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CCRN a good stock to buy?

13F Pro's AI-powered analysis of CROSS COUNTRY HEALTHCARE INC (CCRN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CCRN are available on the CCRN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CCRN is classified as a small company.

Which hedge funds own CCRN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CCRN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CROSS COUNTRY HEALTHCARE INC's investment landscape.